Goldman Sachs’s Inspire Corporate Bond ETF IBD Stock Holding History
Bought
Maintained
Sold
Other funds holding IBD
IA
FA
CFD
BFS
II
OFS
PFG
PAW
UCFA
Goldman Sachs's IBD Position: Q2 2026 in Review
Goldman Sachs reduced its Inspire Corporate Bond ETF (IBD) stake by 43% in Q2 2026, selling an estimated $2.03M and leaving 114,735 shares worth $2.73M. The position accounts for ﹤0.01% of the portfolio, ranked #4428.
Goldman Sachs first reported a position in IBD in Q3 2022 and has held it in 7 quarters since. The position peaked at $4.77M in Q1 2026. 110 funds tracked by Wall St. Rank hold IBD as of Q2 2026.
- Goldman Sachs held 114,735 shares of Inspire Corporate Bond ETF worth $2.73M as of Q2 2026.
- Goldman Sachs sold 85,266 Inspire Corporate Bond ETF shares in Q2 2026, an estimated $2.03M.
- Inspire Corporate Bond ETF made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #4428 holding.
- Goldman Sachs first reported a position in Inspire Corporate Bond ETF in Q3 2022 and has held it in 7 quarters since.
- Goldman Sachs's Inspire Corporate Bond ETF position peaked at $4.77M in Q1 2026.
- 110 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.